Australia’s CSL Faces Union Threat To Disrupt Foreign-Bound Plasma
This article was originally published in PharmAsia News
Executive Summary
Australian plasma maker CSL is facing possible production problems, particularly for processing foreign plasma, as a dispute with its unions draws on.